The company sold 34.1518 million shares globally, with the Hong Kong public offering accounting for 10% and the international offering accounting for 90%. The final sale price was HK$13.5 per share, with a net raise of approximately HK$391.6 million from the global offering
According to the Zhitong Finance App, Shenghe Biotech (02898) announced the allotment results. The company sold 34.1518 million shares globally, the Hong Kong public sale accounted for 10%, and the international sale accounted for 90%. The final sale price was HK$13.5 per share, with a net raise of approximately HK$391.6 million from the global offering. For each lot of 200 shares, shares will start trading on the Stock Exchange at 9:00 a.m. (Hong Kong time) on May 24, 2024 (Friday).
Among them, the Hong Kong public sale received 10.08 times the subscription, and the international sale received 1.27 times the subscription.